HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tauopathies

Neurodegenerative disorders involving deposition of abnormal tau protein isoforms (TAU PROTEINS) in neurons and glial cells in the brain. Pathological aggregations of tau proteins are associated with mutation of the tau gene on chromosome 17 in patients with ALZHEIMER DISEASE; DEMENTIA; PARKINSONIAN DISORDERS; progressive supranuclear palsy (SUPRANUCLEAR PALSY, PROGRESSIVE); and corticobasal degeneration.
Also Known As:
Tauopathy
Networked: 2793 relevant articles (111 outcomes, 306 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Alzheimer Disease (Alzheimer's Disease)
2. Tauopathies
3. Neuroinflammatory Diseases
4. Neurodegenerative Diseases (Neurodegenerative Disease)
5. Parkinson Disease (Parkinson's Disease)

Experts

1. Trojanowski, John Q: 80 articles (01/2022 - 05/2002)
2. Lee, Virginia M-Y: 60 articles (01/2021 - 06/2002)
3. Buée, Luc: 47 articles (01/2022 - 01/2002)
4. Dickson, Dennis W: 40 articles (01/2022 - 06/2002)
5. Hasegawa, Masato: 33 articles (11/2022 - 08/2003)
6. Goedert, Michel: 33 articles (01/2022 - 03/2002)
7. Novak, Michal: 31 articles (01/2020 - 08/2006)
8. Sahara, Naruhiko: 30 articles (05/2022 - 06/2002)
9. Higuchi, Makoto: 27 articles (01/2022 - 07/2002)
10. Avila, Jesús: 26 articles (01/2022 - 03/2002)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Tauopathies:
1. Proteins (Proteins, Gene)FDA Link
2. tau Proteins (tau Protein)IBA
3. Amyloid (Amyloid Fibrils)IBA
4. Peptides (Polypeptides)IBA
5. Amyloid beta-PeptidesIBA
6. Carrier Proteins (Binding Protein)IBA
7. Biomarkers (Surrogate Marker)IBA
8. AntibodiesIBA
9. VaccinesIBA
10. Protein Isoforms (Isoforms)IBA

Therapies and Procedures

1. Therapeutics
2. Immunotherapy
3. Transplantation
4. Oral Administration
5. Ligation